Drug profile · INN
indigotindisulfonate sodium
BLUDIGO
indigotindisulfonate sodium (BLUDIGO) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — indigotindisulfonate sodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
indigotindisulfonate sodium (BLUDIGO) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is indigotindisulfonate sodium?
indigotindisulfonate sodium (BLUDIGO) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for indigotindisulfonate sodium?
BLUDIGO is a marketed brand name for indigotindisulfonate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of indigotindisulfonate sodium?
indigotindisulfonate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.